fda removes semaglutide shortage list 2025 from drug february semaglutide no longer available On February 21, 2025, the FDA announced that semaglutide, the active ingredient Federal judge upholds FDA's removal

Discuss any concerns with your healthcare provider

Clarify Your Purpose Defining your deeper motivations for weight loss can keep you inspired and focused

However, if you notice signs like redness with warmth, pus, fever, or severe pain, its time to call your healthcare provider

The American Diabetes Association Standards of Care acknowledge gastrointestinal tolerability as a key consideration when initiating GLP-1 receptor agonist therapy, recommending gradual dose titration to minimize these effects

But some people taking the medication do, in fact, experience them because of the rapid weight loss from the drug

Important: Microdosing has not been evaluated in large randomized clinical trials